These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 1347247

  • 1. Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA).
    Paris JM, Cunningham KA.
    Brain Res Bull; 1992 Jan; 28(1):115-9. PubMed ID: 1347247
    [Abstract] [Full Text] [Related]

  • 2. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.
    Battaglia G, Yeh SY, De Souza EB.
    Pharmacol Biochem Behav; 1988 Feb; 29(2):269-74. PubMed ID: 2452449
    [Abstract] [Full Text] [Related]

  • 3. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI, Murray TK, Green AR.
    Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
    [Abstract] [Full Text] [Related]

  • 4. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).
    Slikker W, Ali SF, Scallet AC, Frith CH, Newport GD, Bailey JR.
    Toxicol Appl Pharmacol; 1988 Jul; 94(3):448-57. PubMed ID: 2456631
    [Abstract] [Full Text] [Related]

  • 5. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys.
    Kleven MS, Woolverton WL, Seiden LS.
    Brain Res; 1989 May 29; 488(1-2):121-5. PubMed ID: 2472850
    [Abstract] [Full Text] [Related]

  • 6. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.
    O'Hearn E, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME.
    J Neurosci; 1988 Aug 29; 8(8):2788-803. PubMed ID: 2457659
    [Abstract] [Full Text] [Related]

  • 7. Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography.
    Battaglia G, Sharkey J, Kuhar MJ, de Souza EB.
    Synapse; 1991 Aug 29; 8(4):249-60. PubMed ID: 1681594
    [Abstract] [Full Text] [Related]

  • 8. Lack of neurotoxicity after intra-raphe micro-injections of MDMA ("ecstasy").
    Paris JM, Cunningham KA.
    NIDA Res Monogr; 1990 Aug 29; 105():333-4. PubMed ID: 1715034
    [No Abstract] [Full Text] [Related]

  • 9. 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose.
    Esteban B, O'Shea E, Camarero J, Sanchez V, Green AR, Colado MI.
    Psychopharmacology (Berl); 2001 Mar 29; 154(3):251-60. PubMed ID: 11351932
    [Abstract] [Full Text] [Related]

  • 10. 3,4-Methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by L-tryptophan.
    Sprouse JS, Bradberry CW, Roth RH, Aghajanian GK.
    Eur J Pharmacol; 1990 Mar 27; 178(3):313-20. PubMed ID: 1971220
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin.
    Sprouse JS, Bradberry CW, Roth RH, Aghajanian GK.
    Eur J Pharmacol; 1989 Aug 29; 167(3):375-83. PubMed ID: 2572435
    [Abstract] [Full Text] [Related]

  • 13. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI, Green AR.
    Br J Pharmacol; 1994 Jan 29; 111(1):131-6. PubMed ID: 7516800
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB.
    J Pharmacol Exp Ther; 1987 Sep 29; 242(3):911-6. PubMed ID: 2443644
    [Abstract] [Full Text] [Related]

  • 16. Reduction of [3H]6-nitroquipazine-labelled 5-hydroxytryptamine uptake sites in rat brain by 3,4-methylenedioxymethamphetamine.
    Hashimoto K, Goromaru T.
    Fundam Clin Pharmacol; 1990 Sep 29; 4(6):635-41. PubMed ID: 1710592
    [Abstract] [Full Text] [Related]

  • 17. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
    Mokler DJ, Robinson SE, Rosecrans JA.
    Eur J Pharmacol; 1987 Jun 19; 138(2):265-8. PubMed ID: 2887440
    [Abstract] [Full Text] [Related]

  • 18. Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans.
    McCann UD, Ridenour A, Shaham Y, Ricaurte GA.
    Neuropsychopharmacology; 1994 Apr 19; 10(2):129-38. PubMed ID: 7517677
    [Abstract] [Full Text] [Related]

  • 19. Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate.
    Ali SF, Newport GD, Scallet AC, Binienda Z, Ferguson SA, Bailey JR, Paule MG, Slikker W.
    Neurotoxicol Teratol; 1993 Apr 19; 15(2):91-6. PubMed ID: 7685472
    [Abstract] [Full Text] [Related]

  • 20. Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity.
    Bai F, Lau SS, Monks TJ.
    Chem Res Toxicol; 1999 Dec 19; 12(12):1150-7. PubMed ID: 10604863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.